You Have Just Been Told You Have AMD. What Now?

The appointment takes eleven minutes. Somebody says age-related macular degeneration, possibly adds a word like drusen, tells you to come back in a year, and you are back in the car park holding a diagnosis and no idea what it means for Tuesday.

Then you look it up, and the internet hands you a supplement.

The question to ask before any other

Most people are told they have macular degeneration. Far fewer are told which kind and how far along, and that second half is where all the useful information lives.

There are four answers you might get, and they lead to genuinely different places.

1. 01Early dry AMD. Small or medium drusen, and according to the National Eye Institute it usually causes no symptoms at all. This is the stage where the honest advice is monitoring and lifestyle, and where supplement evidence runs out.
2. 02Intermediate dry AMD. Larger drusen, sometimes mild central blurriness or trouble in low light. This is the group both AREDS trials were run in, and the only group where the supplement numbers mean anything.
3. 03Late dry AMD. Tissue loss at the macula, with a blurry or missing area near the centre of vision. Sometimes called geographic atrophy.
4. 04Wet AMD. New leaking vessels under the retina. Always classed as late stage, and treated by an ophthalmologist rather than managed at home. We go through how the two differ and why it changes everything separately.

If your letter or your clinic notes say something like bilateral large drusen, or intermediate AMD, or advanced AMD in the right eye, that is your answer and you already have it.

About the fear of making the wrong choice

This comes up constantly and it is worth naming directly, because the fear is usually pointed at the wrong thing.

People arrive terrified of choosing the wrong bottle. Whether it should be this brand or that one, softgel or tablet, with omega-3 or without. That decision is close to irrelevant. Products that reproduce the tested formulation are interchangeable, and we wrote out what actually separates one from another if you want the detail.

The choices that carry real weight are duller than that:

• Knowing your stage, so that anything you do next is aimed at the right target.
• Actually going back when they tell you to, in a year or two years, when nothing feels wrong.
• Checking your vision at home and knowing which change means today rather than next month.
• Stopping smoking, if that applies, because nothing else on this page competes with it.

None of those is a purchase. That is the part the supplement aisle cannot help you with, and it is most of the value available.

The bit you do at home, and why it matters

Dry AMD can turn into wet AMD, and the National Eye Institute is blunt about the timing: any stage of dry AMD can turn into wet, and wet AMD is always late stage. It does not politely wait for your next appointment.

Which is why home monitoring exists. The standard tool is an Amsler grid, a square of graph paper with a dot in the middle. The American Academy of Ophthalmology's instructions are specific: hold it 12 to 15 inches from your face in good light, cover one eye, look at the centre dot, and notice whether the lines around it stay straight.

Then the other eye. Every day.

One eye at a time is the whole point. With both eyes open, the good eye fills in what the other one has lost, and people routinely discover a substantial blind patch only when something covers the better eye by accident.

Now the supplement question, in its proper place

You have probably already been told to take something. Possibly by the clinic, possibly by a relative, possibly by an advert that followed you home.

Here is where the evidence actually sits.

The original AREDS trial ran in people who already had intermediate AMD, or advanced AMD in one eye. In that group, five-year progression to advanced AMD was 28% on placebo and 20% on the formulation. Useful, real, and much smaller than the packaging implies. We took the whole number apart here.

Participants with only small drusen or pigment changes had a 1.3% probability of progressing over the same five years. AREDS2 did not enrol people with early AMD at all, and the National Eye Institute says why in plain terms: the first trial had shown no benefit for them.

So the sequence is: stage first, then the conversation with your ophthalmologist, then a product. Not the other way round. Buying before you know your stage is the one genuinely wasteful move available here, and it is the one the internet pushes hardest.

Two things that outrank everything above

Smoking

If you smoke, this is the paragraph that matters and the rest is detail. Smoking is among the strongest modifiable risk factors for macular degeneration, and the American Academy of Ophthalmology puts it alongside age and family history rather than below them. No supplement in this article competes with stopping.

There is a second reason to raise it here. The original AREDS formula contained beta-carotene, and in the AREDS2 cohort beta-carotene was associated with nearly double the odds of lung cancer at ten years, concentrated in former smokers. If you have ever smoked, that ingredient is the one to check for by name on any box you are handed.

Blood pressure, blood sugar, and what is on the plate

The retina is fed by the smallest vessels in the body, so vascular health shows up there early. The National Eye Institute's own prevention advice for AMD is unglamorous and consistent: manage blood pressure and cholesterol, and eat leafy greens.

None of that is a treatment for AMD and we are not presenting it as one. It is the part of your risk that is still moving, and unlike your age or your genes it is the part you can push on.

Four things not to do this week

1. 01Do not buy anything before you know your stage. It is the cheapest mistake to avoid and the most common one to make.
2. 02Do not believe anything promising restoration. Nothing available reverses macular damage that has already happened. Both AREDS trials measured whether eyes got worse more slowly, not whether anyone got better.
3. 03Do not skip the follow-up because nothing feels different. Early AMD has no symptoms by definition. Feeling fine is not information about your retina.
4. 04Do not read for six hours tonight. You have a condition that is usually measured in years and monitored in annual appointments. There is no decision here that has to be made before morning.

The shape of the next twelve months

For most people newly told they have dry AMD, the year looks like this. You find out your stage. You check one eye at a time at home, most days, and it stays the same. You go back when they ask you to. If your stage warrants it you take a formulation that shifts your odds by a modest and real amount. If it does not, you save the money.

That is genuinely most of it. It is not a satisfying answer, because there is no action in it big enough to match how the diagnosis felt. But the alternative on offer is buying things, and buying things is not the same as doing something.